Alabama State University partnered with ViiV Healthcare during its 2024 Homecoming to address HIV prevention and awareness.
ViiV Healthcare sponsored events to address the climbing rates of HIV infections on HBCU campuses and the surrounding Black ...
HHS breaks some notable new ground by proposing to account for receipt of HIV pre-exposure prophylaxis (PrEP) when ...
October 09, 2024 Following Rep. Schiff, Sen. Smith’s Urging, CMS to Expand PrEP Coverage Under Medicare. Washington, D.C.— ...
ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries
ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries: London, UK Wednesday, October 9, 2024, 12:00 Hrs [IST] GSK plc announced that ...
Rabies has the dubious distinction of having the worst case fatality rate of any disease. The mortality rate is almost 100 ...
Gilead is looking towards approval of lenacapavir as HIV PrEP after reporting near-perfect efficacy in the PURPOSE-1 and ...
US antivirals specialist Gilead Sciences has released additional data from its pivotal Phase III PURPOSE 2 trial providing an ...
ViiV Healthcare has announced plans to triple its annual supply of long-acting cabotegravir for HIV pre-exposure prophylaxis ...
Hosted on MSN1d
Access questions hang over Gilead's HIV shotA new, long-acting shot to prevent HIV could represent a turning point in efforts to reduce cases around the world — if ...
Doxycycline post-exposure prophylaxis increases tetracycline resistance genes in the gut, without significantly affecting ...
Gilead Sciences Inc. (GILD) announced that additional data from its pivotal Phase 3 PURPOSE 2 trial demonstrated a 96% reduction in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback